At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Stereotactic radiation Arm 1 +3 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer
In Brief
A clinical study evaluating Stereotactic radiation Arm 1, Stereotactic radiation Arm 2, and 2 other interventions for Lung Cancer. Completed, enrolled 12 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate the efficacy and toxicity stereotactic body radiation (SBRT) as consolidation following standard chemoradiation for patients with stage III non-small cell lung cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States
CollaboratorsMemorial Hospital of Rhode Island
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
First PostedAug 2012
Primary CompletionMar 2015
Study CompletionMay 2017
TodayJul 2026
First PostedAug 3, 2012
Enrollment StartApr 1, 2012
Primary CompletionMar 1, 2015
Study CompletionMay 16, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 13.9 years ago
Interventions
Stereotactic radiation Arm 1radiation
Dose Levels Dose per Fraction Total Dose 1 8 Gy 16 Gy
Stereotactic radiation Arm 2radiation
Dose Levels Dose per Fraction Total Dose 2 10 Gy 20 Gy
Stereotactic radiation Arm 3radiation
Dose Levels Dose per Fraction Total Dose 3 12 Gy 24 Gy
Stereotactic radiation Arm 4radiation
Dose Levels Dose per Fraction Total Dose 4 14 Gy 28 Gy